A method for predicting the survival time and response to treatment of patients suffering from solid cancer using at least seven gene signatures

摘要

The task of solving the present invention is to provide a method and kit for predicting the duration and responsiveness of patients suffering from solid cancer.The present invention is for tumor samples obtained from patients, CCR2, cd3d, cd3e, cd3g, CD8a, CXCL10, CXCL11, gzma, gzmB, gzmk, gzmm, IL-15, IRF1, PRF1, STAT1, CD69, ICOS, CXCR3, STAT4, and It is characterized that the survival time and responsiveness of patients can be predicted by determining the gene expression level of at least seven genes selected from the group consisting of CCL2 and TBX21.No selection